Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05235711 · ClinicalTrials.gov registry record
The Role of Interferon-gamma in Immune Responses to Invasive Candidiasis
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 87
- Enrollment target
NCT05235711: Completed study, sponsored by Mayo Clinic.
NCT05235711 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 87 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05235711 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 87 participants
- Enrollment target
Study Summary
The purpose of the study is to investigate the role of the human immune response to candidemia/invasive candidiasis as it relates to the cytokine interferon-gamma.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2022-02-10 |
| Est. Completion | 2024-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05235711
The ClinicalTrials.gov registry entry for NCT05235711 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05235711 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05235711 about?
NCT05235711 is a clinical study titled "The Role of Interferon-gamma in Immune Responses to Invasive Candidiasis". The purpose of the study is to investigate the role of the human immune response to candidemia/invasive candidiasis as it relates to the cytokine interferon-gamma.
What is the current status of trial NCT05235711?
This trial is currently completed. The enrollment target is 87 participants. The study started on 2022-02-10. Estimated completion is 2024-08-31.
Who is sponsoring clinical trial NCT05235711?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.